Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...

Cancer medicine has changed dramatically in the last few years, and chemotherapy too has changed with it. Public perception, however, remains stuck in the past. TheHealthSite.com ...

Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles ...

The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...

Chemotherapy saves lives, but for early-stage breast cancer, it may sometimes do more harm than good. An oncologist explains ...

You might get just one chemotherapy drug or a combination of them. Using a combination can make your treatment more effective because each drug attacks cancer in a different way. It also lowers the ...

Patients with solid tumors, such as breast and gastrointestinal cancers, who also have clonal hematopoiesis of indeterminate ...

Chemotherapy for stomach cancer can help slow the disease’s growth and control symptoms. However, it may cause some side effects. People with stomach cancer have cells in their stomach that grow ...

Of 882 participants enrolled, 128 had PD-L1 CPS < 1 and 373 had CPS 1-19. For pembrolizumab versus cetuximab-chemotherapy, the median overall survival was 7.9 versus 11.3 months in the PD-L1 CPS < 1 ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...